Alpine Immune Sciences Inc (NASDAQ:ALPN)

10.43
Delayed Data
As of Oct 22
 -0.21 / -1.97%
Today’s Change
7.21
Today|||52-Week Range
16.37
-17.22%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Decheng Capital Llc
Director
Buy9/17/20211,542,553$9.40$14.5M+5.50%
Decheng Capital Llc
Buy9/17/20211,542,553$9.40$14.5M+5.50%
Orbimed Advisors Private Equity
Director
Buy9/17/2021585,106$9.40$5.5M+5.50%
Orbimed Advisors Private Equity
Director
Buy9/17/2021585,106$9.40$5.5M+5.50%
Orbimed Advisors Private Equity
Director
Buy9/17/2021425,531$9.40$4.0M+5.50%
Orbimed Advisors Private Equity
Director
Buy9/17/2021425,531$9.40$4.0M+5.50%
Alpine Bioventures Gp Llc
Director
Sale9/17/2021400,000$9.40$3.8M+5.50%
Alpine Bioventures Gp Llc
Executive Chairman & Chief Investment Officer
Sale9/17/2021400,000$9.40$3.8M+5.50%
Alpine Bioventures Gp Llc
Sale9/17/2021400,000$9.40$3.8M+5.50%
Gold Mitchell H
Executive Chairman & Chief Investment Officer
Sale9/17/202145,262$10.01$453.1K+5.50%
Page of 4